NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
17.66
+0.35 (2.02%)
At close: Aug 11, 2026, 4:00 PM EDT
17.75
+0.09 (0.51%)
After-hours: Aug 11, 2026, 6:23 PM EDT
NovoCure Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, NovoCure stock has a consensus rating of "Buy" and an average price target of $27.14. The average 1-year stock price forecast is 53.68% higher than the current stock price, while the lowest is $17 (-3.74%) and the highest is $52 (+194.45%).
Price Target: $27.14 (+53.68%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NovoCure stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Maintains $18 → $20 | Hold | Maintains | $18 → $20 | +13.25% | Jul 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $29 | Buy | Maintains | $29 | +64.21% | Jul 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $52 | Buy | Reiterates | $52 | +194.45% | Jul 23, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $17 | Hold | Maintains | $17 | -3.74% | Jul 13, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $14 → $17 | Hold | Reiterates | $14 → $17 | -3.74% | May 4, 2026 |
Financial Forecast
Revenue This Year
725.82M
from 655.35M
Increased by 10.75%
Revenue Next Year
804.39M
from 725.82M
Increased by 10.82%
EPS This Year
-1.25
from -1.22
EPS Next Year
-0.92
from -1.25
EPS and Forward PE are based on non-GAAP adjusted numbers.